The Leukemia & Lymphoma Society Available to Comment on FDA Approval of Seattle Genetics’ Adcetris, First New Treatment for Hodgkin Lymphoma Since 1977
The Leukemia & Lymphoma Society Available to Comment on FDA Approval of Seattle Genetics’ Adcetris, First New Treatment for Hodgkin Lymphoma Since 1977 Adcetris also a Therapy for Anaplastic Large Cell Lymphoma PR Newswire WHITE PLAINS, N.Y., Aug. 19, 2011 WHITE PLAINS, N.Y. , Aug […]